TrialCritical care (London, England)2025

Adjunctive terlipressin versus placebo in the treatment of refractory septic shock: a randomized, placebo-controlled trial.

Surat Tongyoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.